EU endorses phased approach for assessing risk of nanomaterial-containing devices
This article was originally published in Clinica
Executive Summary
The European Commission's scientific committee on new and emerging risks, SCENIHR, has issued its final guidance on the risk assessment of medical devices that incorporate nanomaterials. To avoid unnecessary testing of such devices, SCENIHR recommends a four-step approach to carry out the risk assessment process.